Desensitization of the NMDA receptor complex by glycinergic ligands in cerebellar granule cell cultures

Brain Res. 1993 Feb 19;603(2):207-14. doi: 10.1016/0006-8993(93)91239-o.

Abstract

Glutamate neurotoxicity was examined in cultured cerebellar granule neurons following both prolonged (20-24 h) and brief (45 min) exposure to compounds acting at strychnine-insensitive glycine receptors. Glutamate neurotoxicity was reduced in a concentration-dependent fashion by brief exposure to the glycine partial agonists 1-aminocyclopropanecarboxylic acid (ACPC) and (+-)-3-amino-1-hydroxy-2-pyrrolidone (HA-966) and the competitive antagonist, 7-chlorokynurenic acid (7-CK) with a rank order efficacy: 7-CK > HA-966 > ACPC. Neither D-cycloserine (D-CS) nor glycine affected neurotoxicity produced by maximum glutamate concentrations, while glycine but not D-CS augmented the effects of submaximum glutamate concentrations. Prolonged exposure of cultures to either full (glycine) or partial agonists (ACPC, D-CS, HA-966) abolished the neuroprotective effects of ACPC and significantly diminished the neuroprotective effects of HA-966. In contrast, the neuroprotective effects of 7-CK were only marginally reduced by prolonged exposure to glycinergic ligands, while the neuroprotection afforded by compounds acting at other loci on the NMDA receptor complex (e.g. 2-amino-5-phosphonopentanoate (APV) and dizocilpine (MK-801)) were unaltered. These effects may represent homologous desensitization of the NMDA receptor complex at its strychnine-insensitive glycine receptor induced by prolonged exposure to glycinergic agonists and partial agonists. Nonetheless, levels of the NMDA receptor subunit zeta 1 mRNA were unaffected by prolonged exposure to ACPC, indicating the apparent desensitization could involve a post-translational modification of the NMDA receptor complex.

MeSH terms

  • 2-Amino-5-phosphonovalerate / pharmacology
  • Amino Acids / pharmacology
  • Amino Acids, Cyclic*
  • Analysis of Variance
  • Animals
  • Base Sequence
  • Blotting, Northern
  • Cells, Cultured
  • Cerebellum / cytology
  • Cerebellum / physiology*
  • Dizocilpine Maleate / pharmacology
  • Dose-Response Relationship, Drug
  • Glutamates / pharmacology*
  • Glutamic Acid
  • Glycine / physiology
  • Kinetics
  • Kynurenic Acid / analogs & derivatives
  • Kynurenic Acid / pharmacology
  • Molecular Sequence Data
  • Neurons / cytology
  • Neurons / drug effects
  • Neurons / physiology*
  • Neurotoxins / pharmacology
  • Oligodeoxyribonucleotides
  • Polymerase Chain Reaction / methods
  • Pyrrolidinones / pharmacology
  • RNA, Messenger / genetics
  • RNA, Messenger / metabolism
  • Rats
  • Rats, Sprague-Dawley
  • Receptors, N-Methyl-D-Aspartate / antagonists & inhibitors
  • Receptors, N-Methyl-D-Aspartate / genetics
  • Receptors, N-Methyl-D-Aspartate / physiology*
  • Strychnine / pharmacology
  • Time Factors

Substances

  • Amino Acids
  • Amino Acids, Cyclic
  • Glutamates
  • Neurotoxins
  • Oligodeoxyribonucleotides
  • Pyrrolidinones
  • RNA, Messenger
  • Receptors, N-Methyl-D-Aspartate
  • 1-aminocyclopropane-1-carboxylic acid
  • Glutamic Acid
  • Dizocilpine Maleate
  • 2-Amino-5-phosphonovalerate
  • 1-hydroxy-3-amino-2-pyrrolidone
  • Kynurenic Acid
  • Strychnine
  • 7-chlorokynurenic acid
  • Glycine